Trending...
- LS2 Partners with Angels Of Dirt's "Next Chapter Racer" Series Celebrating Women and Girls in Motorsports
- WebDrafter Welcomes Honey in the Hollow as a New Marketing Client
- Hannk And Zubie Join Forces To Shape The Next Generation Of Connected Vehicle Telematics
PITTSBURGH, Aug. 6, 2024 ~ Journalist: MolecuLight Corp., a leading company in fluorescence imaging technology for detecting harmful bacteria in wound care, has recently announced the publication of a peer-reviewed clinical research study showcasing the transformative capabilities of their technology. The study, conducted on 167 Medicare beneficiaries across 55 Long Term Care (LTC) and Skilled Nursing Facilities (SNF) in the US, highlights the significant improvements in pressure injury outcomes and infection control achieved with the use of MolecuLight.
The article, titled "Improving Wound Healing and Infection Control in Long-term Care with Bacterial Fluorescence Imaging," was published by Martha R. Kelso and her colleagues in the latest edition of Advances in Skin & Wound Care journal. The researchers reported impressive results, showing a remarkable improvement in pressure injury outcomes among patients with complex healing challenges. This serves as a testament to the effectiveness of MolecuLight technology, even in the most challenging patient cases.
More on The PennZone
The study compared outcomes between patients who received standard care alone and those who had MolecuLight real-time fluorescence integrated into their treatment plan. The results showed that patients who were imaged with MolecuLight saw a 71% increase in wound healing by 12 weeks, healed 28% faster, and were 1.8 times more likely to heal their wound within this time frame. Additionally, there was a significant decrease (75%) in severe infection complications such as cellulitis, osteomyelitis, gangrene, sepsis, and wound-related hospitalization when MolecuLight was used to guide patient care.
Lead author Martha R. Kelso expressed her excitement about these findings stating, "We are very excited to share with the world through concrete findings what we have been experiencing firsthand with our LTC/SNF patients." She further added that "the positive effects that the MolecuLight technology has on all patients, even those who are severely sick and compromised, is outstanding. Increasing healing rates, shortening healing times, and avoiding complications is how you make a difference. All patients deserve the best!"
More on The PennZone
Anil Amlani, CEO of MolecuLight, also shared his enthusiasm for these groundbreaking results. "We are thrilled to see such compelling evidence of the impact our technology can have on patient outcomes, particularly in such a vulnerable and systematically neglected patient population." He emphasized that "the significant improvements in wound healing and the dramatic reduction in infection complications underscore the potential of MolecuLight to revolutionize wound care, in any place of service and against the most challenging of clinical backgrounds."
This research serves as another example of MolecuLight's commitment to improving patient care and advancing the field of wound management. With these remarkable outcomes now published in a peer-reviewed journal, it is hoped that more healthcare professionals will adopt this technology to provide better care for their patients.
The article, titled "Improving Wound Healing and Infection Control in Long-term Care with Bacterial Fluorescence Imaging," was published by Martha R. Kelso and her colleagues in the latest edition of Advances in Skin & Wound Care journal. The researchers reported impressive results, showing a remarkable improvement in pressure injury outcomes among patients with complex healing challenges. This serves as a testament to the effectiveness of MolecuLight technology, even in the most challenging patient cases.
More on The PennZone
- Revinate launches hospitality's first data activation platform
- HLN Consulting Names Lilly Kan as Its First Chief Executive Officer
- BitTitan Accelerates Large-Scale Document Migrations with MigrationWiz
- Clearnetworx Deploys netElastic vBNG, CGNAT And netVision To Power Fiber Expansion Across Colorado's Western Slope
- Glenn Strange - Iconic Horror actor of Universal Studios Frankenstein's Monster Fame Honored
The study compared outcomes between patients who received standard care alone and those who had MolecuLight real-time fluorescence integrated into their treatment plan. The results showed that patients who were imaged with MolecuLight saw a 71% increase in wound healing by 12 weeks, healed 28% faster, and were 1.8 times more likely to heal their wound within this time frame. Additionally, there was a significant decrease (75%) in severe infection complications such as cellulitis, osteomyelitis, gangrene, sepsis, and wound-related hospitalization when MolecuLight was used to guide patient care.
Lead author Martha R. Kelso expressed her excitement about these findings stating, "We are very excited to share with the world through concrete findings what we have been experiencing firsthand with our LTC/SNF patients." She further added that "the positive effects that the MolecuLight technology has on all patients, even those who are severely sick and compromised, is outstanding. Increasing healing rates, shortening healing times, and avoiding complications is how you make a difference. All patients deserve the best!"
More on The PennZone
- Creole101 Launches Multilingual Dictionary App with 50,000+ Entries, Vocabulary Games and Haitian Cultural Resources
- Hilton Waikiki Beach Resort & Spa Introduces Level 37 Sky Lounge by Casamigos
- Self-Published Dad's Santa Book Finally Found After 3 Years on Amazon
- Meta Partnership Expanding as Omni One Orders Surge 3X -New Consumer Bundles, Defense Opportunities & AI Robotics: Virtuix Holdings: N A S D A Q: VTIX
- Roots for Boots to Participate in 2026 Adams County Community Foundation Giving Spree
Anil Amlani, CEO of MolecuLight, also shared his enthusiasm for these groundbreaking results. "We are thrilled to see such compelling evidence of the impact our technology can have on patient outcomes, particularly in such a vulnerable and systematically neglected patient population." He emphasized that "the significant improvements in wound healing and the dramatic reduction in infection complications underscore the potential of MolecuLight to revolutionize wound care, in any place of service and against the most challenging of clinical backgrounds."
This research serves as another example of MolecuLight's commitment to improving patient care and advancing the field of wound management. With these remarkable outcomes now published in a peer-reviewed journal, it is hoped that more healthcare professionals will adopt this technology to provide better care for their patients.
0 Comments
Latest on The PennZone
- HSS Medical Supply Celebrates One-Year Anniversary of Its Top Performing Sales Team
- Jacombs Tickets Partners with UEFA to Offer Champions League Tickets
- Corner Property Management Awarded Management Contract with Clock Towers Condominium Association
- WebDrafter Welcomes Honey in the Hollow as a New Marketing Client
- Geospatial Innovation Comes to Sacramento: FOSS4G NA 2026
- Tulsa Air & Space Museum Launches "Give $16 for the F-16" Challenge to Bring Thunderbird Home for Veterans Day
- Hannk And Zubie Join Forces To Shape The Next Generation Of Connected Vehicle Telematics
- Coinfiliate Launches Platform to Helps Shoppers Earn Cashback and Creators Earn Referral Rewards
- Champions for Education to Honor United Way of the Greater Lehigh Valley and Induct Three Leaders
- Holiday Gambling Spending Expected to Rise 12% in December
- RAS AP Consulting Issues National Compliance Alert and Launches Q4 2026 AP Readiness Program Ahead of IRS FIRE → IRIS Cutover
- Free Senior Housing Webinar Helps Families Plan for Aging Before a Crisis Forces Difficult Decisions
- Claude Zdanow named Managing Director in Miami, Florida
- YWCA Hanover Celebrates Opening of New Children's Learning Academy
- Pregis Launches Sharp InfinX: On-Demand Rightsized Mailing System Delivering a Precision-Sized Mailer for Every Order
- netElastic Announces vBNG And CGNAT 2.0 General Availability
- Postmortem Pathology Highlights Private Autopsy Options for Las Vegas Families During Summer Months
- Postmortem Pathology Offers Sacramento Families Independent Answers on a Short Timeline
- Philly ECM Programming Announces Mobile Module Programming for Philadelphia Repair Shops
- NEW Three Fully Furnished Single-Family Model Homes at Heritage at South Brunswick